Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8712678rdf:typepubmed:Citationlld:pubmed
pubmed-article:8712678lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:8712678lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8712678lifeskim:mentionsumls-concept:C0677886lld:lifeskim
pubmed-article:8712678lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:8712678lifeskim:mentionsumls-concept:C0017066lld:lifeskim
pubmed-article:8712678lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:8712678lifeskim:mentionsumls-concept:C1336633lld:lifeskim
pubmed-article:8712678lifeskim:mentionsumls-concept:C1160185lld:lifeskim
pubmed-article:8712678lifeskim:mentionsumls-concept:C0332283lld:lifeskim
pubmed-article:8712678pubmed:issue4Alld:pubmed
pubmed-article:8712678pubmed:dateCreated1996-9-10lld:pubmed
pubmed-article:8712678pubmed:abstractTextIn an effort to develop gene therapy for ovarian cancer efficacy and toxicity of adenovirus-mediated transfer of the HSV-TK gene followed by administration of ganciclovir were studied in two human epithelial ovarian cancer cell lines Ov-ca-2774 and Ov-ca-1225. 100% transduction was achieved in both cell lines at MOIs of 7 and 15 as demonstrated by X-Gal staining. No toxicity of virus alone was observed at MOIs up to 30. GCV was not toxic up to 200 micrograms/ml. Cell killing efficacy was shown to be dependent on MOI as well as GCV dose. The "bystander effect" of ADV/RSV-TK was quantified by mixing experiments and found to be dependent on the proportion of ADV/RSV-TK positive cells as well as the GCV dosage. Similar results were observed in both cell lines. ADV/RSV-TK mediated gene therapy may be a promising approach in ovarian cancer.lld:pubmed
pubmed-article:8712678pubmed:languageenglld:pubmed
pubmed-article:8712678pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8712678pubmed:citationSubsetIMlld:pubmed
pubmed-article:8712678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8712678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8712678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8712678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8712678pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8712678pubmed:statusMEDLINElld:pubmed
pubmed-article:8712678pubmed:issn0250-7005lld:pubmed
pubmed-article:8712678pubmed:authorpubmed-author:WooS LSLlld:pubmed
pubmed-article:8712678pubmed:authorpubmed-author:ChenS HSHlld:pubmed
pubmed-article:8712678pubmed:authorpubmed-author:BlochFFlld:pubmed
pubmed-article:8712678pubmed:authorpubmed-author:KiebackD GDGlld:pubmed
pubmed-article:8712678pubmed:authorpubmed-author:TongX WXWlld:pubmed
pubmed-article:8712678pubmed:issnTypePrintlld:pubmed
pubmed-article:8712678pubmed:volume16lld:pubmed
pubmed-article:8712678pubmed:ownerNLMlld:pubmed
pubmed-article:8712678pubmed:authorsCompleteYlld:pubmed
pubmed-article:8712678pubmed:pagination1611-7lld:pubmed
pubmed-article:8712678pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:meshHeadingpubmed-meshheading:8712678-...lld:pubmed
pubmed-article:8712678pubmed:articleTitleAdenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir.lld:pubmed
pubmed-article:8712678pubmed:affiliationDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, USA.lld:pubmed
pubmed-article:8712678pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8712678lld:pubmed